NLRP3 inflammasome components and microRNA‐223‐3p are upregulated in activated MФ and MG at sites of myelin damage, and microRNA‐223‐3p and the small molecule NLRP3 inhibitor MCC950 can inhibit inflammasome activation in MФ and MG in vitro, with MФ being more prone to inflammasome activation compared to MG in vitro [104]. This evidence concerns the gene NLRP3 and myasthenia gravis.